Irinotecan (CPT-11) Clinical Trials
4 recruitingDrug
Phase 32Phase 12Phase 21
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
Gastrointestinal Cancer
Zhejiang Doer Biologics Co., Ltd.186 enrolled1 locationNCT07056777
Recruiting
Phase 3
FOLFOXIRI Plus Bevacizumab With or Without Atezolizumab as 1st Line Treatment of pMMR and IS IC-High Metastatic Colorectal Cancer Patients.
Gruppo Oncologico del Nord-Ovest238 enrolled24 locationsNCT06733038
Recruiting
Phase 3
Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.
Pancreatic Adenocarcinoma Advanced or Metastatic
Gruppo Oncologico del Nord-Ovest340 enrolled28 locationsNCT06897644
Recruiting
Phase 1
UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors
Pediatric Solid Tumor
Sun Yat-sen University39 enrolled1 locationNCT06760117